Ronghua Chen

Ronghua (Ron) Chen, CPA, currently serves as VP of Finance at Aileron Therapeutics, having transitioned into this role in December 2023 after holding the position of Senior Director, Corporate Controller at Reata Pharmaceuticals, Inc. from April 2022 to December 2023. Prior roles include Director, Assistant Controller at Pear Therapeutics (February 2020 - April 2022), Technical Accounting and Financial Analysis Leader at Sanofi (March 2018 - February 2020), and Senior Manager, Accounting & SEC Reporting at Bioverativ, a Sanofi company (March 2017 - March 2018). Ronghua began their career at EY as an Assurance Senior Manager (August 2008 - March 2017) and worked as a Department Manager and Securities Analyst at Guotai Junan Securities Co., Ltd. from July 2001 to April 2005. Educational credentials include a Master's degree in Accounting from Boston College (2006 - 2007) and a Bachelor's degree in Finance from Nanjing University (1997 - 2001).